Pleiotropic effects of laminar flow and statins depend on the Krüppel-like factor-induced lncRNA MANTIS.


Journal

European heart journal
ISSN: 1522-9645
Titre abrégé: Eur Heart J
Pays: England
ID NLM: 8006263

Informations de publication

Date de publication:
07 08 2019
Historique:
received: 30 08 2018
revised: 28 11 2018
accepted: 24 05 2019
pubmed: 22 6 2019
medline: 31 10 2020
entrez: 22 6 2019
Statut: ppublish

Résumé

To assess the functional relevance and therapeutic potential of the pro-angiogenic long non-coding RNA MANTIS in vascular disease development. RNA sequencing, CRISPR activation, overexpression, and RNAi demonstrated that MANTIS, especially its Alu-element, limits endothelial ICAM-1 expression in different types of endothelial cells. Loss of MANTIS increased endothelial monocyte adhesion in an ICAM-1-dependent manner. MANTIS reduced the binding of the SWI/SNF chromatin remodelling factor BRG1 at the ICAM-1 promoter. The expression of MANTIS was induced by laminar flow and HMG-CoA-reductase inhibitors (statins) through mechanisms involving epigenetic rearrangements and the transcription factors KLF2 and KLF4. Mutation of the KLF binding motifs in the MANTIS promoter blocked the flow-induced MANTIS expression. Importantly, the expression of MANTIS in human carotid artery endarterectomy material was lower compared with healthy vessels and this effect was prevented by statin therapy. Interestingly, the protective effects of statins were mediated in part through MANTIS, which was required to facilitate the atorvastatin-induced changes in endothelial gene expression. Moreover, the beneficial endothelial effects of statins in culture models (spheroid outgrowth, proliferation, telomerase activity, and vascular organ culture) were lost upon knockdown of MANTIS. MANTIS is tightly regulated by the transcription factors KLF2 and KLF4 and limits the ICAM-1 mediated monocyte adhesion to endothelial cells and thus potentially atherosclerosis development in humans. The beneficial effects of statin treatment and laminar flow are dependent on MANTIS.

Identifiants

pubmed: 31222221
pii: 5521362
doi: 10.1093/eurheartj/ehz393
doi:

Substances chimiques

Angiogenesis Inducing Agents 0
Hydroxymethylglutaryl-CoA Reductase Inhibitors 0
ICAM1 protein, human 0
KLF4 protein, human 0
Kruppel-Like Factor 4 0
Kruppel-Like Transcription Factors 0
RNA, Long Noncoding 0
Intercellular Adhesion Molecule-1 126547-89-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2523-2533

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Auteurs

Matthias S Leisegang (MS)

Institute for Cardiovascular Physiology, Goethe University, Theodor-Stern-Kai 7, Frankfurt, Germany.
German Center of Cardiovascular Research (DZHK), Partner Site RheinMain, Theodor Stern-Kai 7, Frankfurt, Germany.

Sofia-Iris Bibli (SI)

German Center of Cardiovascular Research (DZHK), Partner Site RheinMain, Theodor Stern-Kai 7, Frankfurt, Germany.
Institute for Vascular Signalling, Goethe University, Theodor Stern-Kai 7, Frankfurt, Germany.

Stefan Günther (S)

Max-Planck-Institute for Heart and Lung Research, ECCPS Bioinformatics and Sequencing Facility, Ludwigstr. 43, Bad Nauheim, Germany.

Beatrice Pflüger-Müller (B)

Institute for Cardiovascular Physiology, Goethe University, Theodor-Stern-Kai 7, Frankfurt, Germany.
German Center of Cardiovascular Research (DZHK), Partner Site RheinMain, Theodor Stern-Kai 7, Frankfurt, Germany.

James A Oo (JA)

Institute for Cardiovascular Physiology, Goethe University, Theodor-Stern-Kai 7, Frankfurt, Germany.
German Center of Cardiovascular Research (DZHK), Partner Site RheinMain, Theodor Stern-Kai 7, Frankfurt, Germany.

Cindy Höper (C)

Institute for Cardiovascular Physiology, Goethe University, Theodor-Stern-Kai 7, Frankfurt, Germany.
German Center of Cardiovascular Research (DZHK), Partner Site RheinMain, Theodor Stern-Kai 7, Frankfurt, Germany.

Sandra Seredinski (S)

Institute for Cardiovascular Physiology, Goethe University, Theodor-Stern-Kai 7, Frankfurt, Germany.
German Center of Cardiovascular Research (DZHK), Partner Site RheinMain, Theodor Stern-Kai 7, Frankfurt, Germany.

Michail Yekelchyk (M)

Max-Planck-Institute for Heart and Lung Research, ECCPS Bioinformatics and Sequencing Facility, Ludwigstr. 43, Bad Nauheim, Germany.

Thomas Schmitz-Rixen (T)

Department of Vascular and Endovascular Surgery, Goethe University, Theodor-Stern-Kai 7, Frankfurt, Germany.

Christoph Schürmann (C)

Institute for Cardiovascular Physiology, Goethe University, Theodor-Stern-Kai 7, Frankfurt, Germany.
German Center of Cardiovascular Research (DZHK), Partner Site RheinMain, Theodor Stern-Kai 7, Frankfurt, Germany.

Jiong Hu (J)

German Center of Cardiovascular Research (DZHK), Partner Site RheinMain, Theodor Stern-Kai 7, Frankfurt, Germany.
Institute for Vascular Signalling, Goethe University, Theodor Stern-Kai 7, Frankfurt, Germany.

Mario Looso (M)

Max-Planck-Institute for Heart and Lung Research, ECCPS Bioinformatics and Sequencing Facility, Ludwigstr. 43, Bad Nauheim, Germany.

Fragiska Sigala (F)

1st Department of Propaedeutic Surgery, University of Athens Medical School, Hippocration Hospital, Etheros 7-9, Athens, Greece.

Reinier A Boon (RA)

German Center of Cardiovascular Research (DZHK), Partner Site RheinMain, Theodor Stern-Kai 7, Frankfurt, Germany.
Institute of Cardiovascular Regeneration, Goethe University, Frankfurt, Theodor-Stern-Kai 7, Germany.
Department of Physiology, VU University Medical Center, De Boelelaan 1118, HV Amsterdam, the Netherlands.

Ingrid Fleming (I)

German Center of Cardiovascular Research (DZHK), Partner Site RheinMain, Theodor Stern-Kai 7, Frankfurt, Germany.
Institute for Vascular Signalling, Goethe University, Theodor Stern-Kai 7, Frankfurt, Germany.

Ralf P Brandes (RP)

Institute for Cardiovascular Physiology, Goethe University, Theodor-Stern-Kai 7, Frankfurt, Germany.
German Center of Cardiovascular Research (DZHK), Partner Site RheinMain, Theodor Stern-Kai 7, Frankfurt, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH